ORAPAZ
cephalexin, ibuprofen, chlorhexidine gluconate kit |
Product Information |
Product Type | HUMAN PRESCRIPTION DRUG | Item Code (Source) | NDC: 73614-417 |
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 73614-417-03 | 1 in 1 CARTON; Type 1: Convenience Kit of Co-Package | 02/10/2025 | |
|
Quantity of Parts |
Part # | Package Quantity | Total Product Quantity |
Part 1 | 1 BOTTLE | 118 mL |
Part 2 | 1 BOTTLE | 30 |
Part 3 | 1 BOTTLE | 30 |
Part 4 | 1 BOTTLE | 118 mL |
|
Part 1 of 4 |
CHLORHEXIDINE GLUCONATE ORAL RINSE
chlorhexidine gluconate oral rinse solution |
|
Product Information |
Item Code (Source) | NDC: 73614-203 |
Route of Administration | DENTAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
CHLORHEXIDINE GLUCONATE (UNII: MOR84MUD8E) (CHLORHEXIDINE - UNII:R4KO0DY52L) | CHLORHEXIDINE GLUCONATE | 1.2 mg in 1 mL |
|
|
Product Characteristics |
Color | blue | Score | |
Shape | | Size | |
Flavor | MINT | Imprint Code | |
Contains | |
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 73614-203-01 | 118 mL in 1 BOTTLE; Type 0: Not a Combination Product | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA075561 | 07/27/2023 | |
|
Part 2 of 4 |
CEPHALEXIN
cephalexin capsule |
|
Product Information |
Item Code (Source) | NDC: 73614-202 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
CEPHALEXIN (UNII: OBN7UDS42Y) (CEPHALEXIN ANHYDROUS - UNII:5SFF1W6677) | CEPHALEXIN ANHYDROUS | 500 mg |
|
|
Product Characteristics |
Color | green (Dark Green Opaque, Light Green Opaque) | Score | no score |
Shape | CAPSULE | Size | 21mm |
Flavor | | Imprint Code |
A;43;500;mg
|
Contains | |
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 73614-202-03 | 30 in 1 BOTTLE; Type 0: Not a Combination Product | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA065253 | 11/16/2005 | |
|
Part 3 of 4 |
IBUPROFEN
ibuprofen tablet, film coated |
|
Product Information |
Item Code (Source) | NDC: 73614-201 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
IBUPROFEN (UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM) | IBUPROFEN | 800 mg |
|
|
Product Characteristics |
Color | white | Score | no score |
Shape | OVAL (CAPLET) | Size | 19mm |
Flavor | | Imprint Code |
BI8
|
Contains | |
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 73614-201-03 | 30 in 1 BOTTLE; Type 0: Not a Combination Product | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA202413 | 05/23/2024 | |
|
Part 4 of 4 |
CHLORHEXIDINE GLUCONATE ORAL RINSE
chlorhexidine gluconate oral rinse solution |
|
Product Information |
Item Code (Source) | NDC: 73614-203 |
Route of Administration | DENTAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
CHLORHEXIDINE GLUCONATE (UNII: MOR84MUD8E) (CHLORHEXIDINE - UNII:R4KO0DY52L) | CHLORHEXIDINE GLUCONATE | 1.2 mg in 1 mL |
|
|
Product Characteristics |
Color | blue | Score | |
Shape | | Size | |
Flavor | MINT | Imprint Code | |
Contains | |
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 73614-203-01 | 118 mL in 1 BOTTLE; Type 0: Not a Combination Product | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA075561 | 07/27/2023 | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 02/10/2025 | |
|